As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for ...

CHICAGO As 2025 begins and millions of Americans start working to keep their New Year’s resolutions, Attorney General Kwame ...